MEEDER ASSET MANAGEMENT INC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$0261
-1.5%
0.00%
Q2 2021$02650.0%0.00%
Q1 2021$0
-100.0%
265
-98.6%
0.00%
-100.0%
Q3 2020$29,000
+20.8%
19,5070.0%0.00%0.0%
Q2 2020$24,000
-4.0%
19,507
-7.6%
0.00%0.0%
Q1 2020$25,000
+316.7%
21,112
+607.3%
0.00%
Q4 2019$6,000
-14.3%
2,985
-6.6%
0.00%
Q3 2019$7,000
-36.4%
3,197
-24.3%
0.00%
-100.0%
Q2 2019$11,000
+120.0%
4,221
+220.3%
0.00%
Q1 2019$5,000
+66.7%
1,3180.0%0.00%
Q4 2018$3,000
-84.2%
1,318
-73.4%
0.00%
-100.0%
Q3 2018$19,000
-99.6%
4,959
+281.5%
0.00%
Q2 2018$4,388,000
+146166.7%
1,3000.0%0.00%
Q1 2018$3,0000.0%1,3000.0%0.00%
Q4 2017$3,000
-40.0%
1,300
+16.1%
0.00%
-100.0%
Q3 2017$5,000
+25.0%
1,120
-33.1%
0.00%
Q2 2017$4,000
-20.0%
1,6730.0%0.00%
Q1 2017$5,000
-68.8%
1,673
-73.5%
0.00%
-100.0%
Q4 2016$16,0006,3190.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 5,408,728$21,040,0001.36%
Palo Alto Investors LP 1,634,608$6,359,0000.37%
WealthTrust Axiom LLC 200,000$778,0000.29%
Granahan Investment Management 1,455,676$5,663,0000.18%
SHEPHERD KAPLAN KROCHUK, LLC 127,846$497,0000.10%
Joel Isaacson & Co., LLC 80,660$314,0000.06%
Cornerstone Capital, Inc. 39,700$154,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 281,650$1,096,0000.02%
Advisor Group, Inc. 131,992$513,0000.01%
INTEGRATED WEALTH COUNSEL, LLC 1,000$4,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders